Buscar
Mostrando ítems 11-20 de 467
Interação entre Hb B2 e Hb S
(2010-02-01)
Hemoglobinopathies and thalassemias are the most common genetic diseases, and in most cases, present as heterozygous. Due to the diversity of hemoglobin variants, specific and complementary methodologies are necessary for ...
The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease
(Associação Brasileira de Divulgação Científica, 2006-10-01)
Sickle cell disease (SCD) is one of the most common inherited diseases in the world and the patients present notorious clinical heterogeneity. It is known that patients with SCD present activation of the blood coagulation ...
Dificuldades no diagnóstico laboratorial das hemoglobinopatias
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2007-09-01)
Há vários tipos de hemoglobinopatias que são caracterizados por variantes das hemoglobinas anormais (ex: Hb S, Hb C, Hb Instáveis,etc) e por talassemias (ex: tal. alfa, tal. beta, tal.beta/delta,etc) As hemoglobinopatias ...
Frequency and spectrum of hemoglobinopathy mutations in a Uruguayan pediatric population
(Sociedade Brasileira de Genética, 2013)
Hemoglobinopathies in newborns from Salvador, Bahia, Northeast Brazil
(2005)
Hemoglobinopathies are hereditary disorders of the hemoglobin molecule with a high prevalence worldwide. Brazil has a prevalence of 0.1 to 0.3% of newborns with sickle cell anemia and 20.0 to 25.0% of heterozygous α2 ...
A Portaria nº 822/01 do Ministério da Saúde e as peculiaridades das hemoglobinopatias em saúde pública no BrasilGovernment Directive MS # 822/01: unique aspects of hemoglobinopathies for public health in Brazil
(Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, 2003)